• Notifications
    This feature only available to registered users.
  • Alerts
    This feature only available to registered users
  • Welcome Guest!
  • Login Signup

Stock [ BUY ] / [ SELL ] Trading Strategies
. [ Show Details ]


Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:





Indicator Windows:





NO
     
LIFE [ aTyr Pharma Inc ]
Last Trade 4.26 Date 7/2/2020
Change % -0.93 % Price Change -0.04
Open 4.13 52 Week High 7.62
High 4.49 52 Week Low 2.13
Low 4.1 Type stock
Volume 41859 Average Volume 336480
Prev Close 4.3 Stock Exchange NASDAQ
Bid 4.22 Ask 4.4
Bid Size 2 Ask Size 1
1st Yr Estimated EPS Growth -0.5425 2nd Yr Estimated EPS Growth 0.3402
2 Years Forward Earning Yield -0.6103 2 Years Forward PE Ratio
2 Years EV/Forward EBIT 2 Years EV/Forward EBITDA
Book Value per Share 4.5007 Book Value Yield 1.0565
Buy Back Yield CAPE Ratio
Cash Return Cash Flow per Share -2.6681
Cash Flow Yield -0.6263 Dividend Rate
Dividend Yield 5 Year Dividend Yield
Earning Yield -0.9953 EV/EBIT
EV/EBITDA EV / Free Cash Flow
EV / Forward EBIT EV / Forward EBITDA
EV / Forward Revenue EV / Pre Tax Income
EV / Revenue EV / Total Asset
Expected Dividend Growth Rate Free Cash Flow per Share -2.7206
Free Caash Flow Ratio Free Cash Flow Yield -0.6386
Forward Calculation Style Forward Dividend Yield
Forward Earning Yield -0.4554 Forward PE Ratio
Forward Return on Asset Forward Return on Equity
Normalized PE Ratio Payout Ratio 0.0
PB Ratio 0.946515 PB Ratio 10 Year Growth
PB Ratio 3 Year Growth 1.020556 Cash Ratio 3 Year Average 74.7293
Price to Cash Flow Ratio PEG Payback
PEG Ratio PE Ratio
PE Ratio 10 Year Average PE Ratio 10 Year Growth
PE Ratio 10 Year High PE Ratio 10 Year Low
PE Ratio 1 Year Avg PE Ratio 1 Year High
PE Ratio 1 Year Low PE Ratio 3 Year Avg
PE Ratio 5 Year Avg PE Ratio 5 Year High
PE Ratio 5 Year Low Free Cash Flow Ratio 10 Year Growth
Free Cash Flow Ratio 3 Year Avg Price Change 1 Month 0.959459
Price to Cash Ratio 0.800232 Price / EBITDA
Price to Sales Ratio 2.24476 Price to Sales Ratio 10 Year Growth
Price to Sales Ratio 3 Year Avg 48.704151 Price to Sales Ratio 5 Year Avg
Sale per Share 1.8978 Sales Yield 0.4455
Sustainable Growth Rate -0.4388 Tangible Book Value per Share 4.5007
Tangible Book Value per Share 3 year Avg 19.5457 Tangible Book Value per Share 5 year Avg 35.7305
Total Asset per Share 5.8168 Total Yield
Working Capital per Share 4.2658 Working Capital per Share 3 Year Avg 22.4021
Working Capital per Share 5 Year Avg 32.8556 Beta 1.905725
12
Company Profile

Life Technologies Corporation operates as a global biotechnology tools company focused on improving the human condition. Its systems, consumables, and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that better the quality of life. Life Technologies? customers work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. The company delivers a range of products and services, including systems, instruments, reagents, and custom services. Its portfolio of products include technologies for capillary electrophoresis based sequencing, next generation sequencing, mass spectrometry, sample preparation, cell culture, RNA interference analysis, functional genomics research, proteomics, and cell biology applications, as well as clinical diagnostic applications and water testing analysis. The company has a presence in approximately 160 countries, and possesses a growing intellectual property estate of approximately 3,100 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems, Inc. It has a strategic partnership agreement with Integrated Biobank of Luxembourg. The company is based in Carlsbad, California.